Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nitrogen‐Containing Heterocyclic Scaffolds as EGFR Inhibitors: Design Approaches, Molecular Docking, and Structure‐Activity Relationships
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
ChemistrySelect (2023) Vol. 8, Iss. 26
Closed Access | Times Cited: 14

Showing 14 citing articles:

Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116535-116535
Closed Access | Times Cited: 6
Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure–activity relationship
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Bioorganic Chemistry (2024) Vol. 152, pp. 107696-107696
Closed Access | Times Cited: 6
Design, synthesis, and biological evaluation of novel 4-(4-ethoxyphenyl)-6-(substituted-phenyl)pyrimidin-2-amine/thiol/hydroxy derivatives as EGFRWT and EGFRT790M inhibitors targeting NSCLC: In-vitro and in-silico exploration
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Journal of Molecular Structure (2025) Vol. 1327, pp. 141227-141227
Closed Access
Green one-pot synthesis of quinoxaline derivatives using sulfo-anthranilic acid functionalized alginate-MCFe2O4 nanostructures: a novel superparamagnetic catalyst with antiproliferative potential
Ying Lai, Ruoyu Zhang
RSC Advances (2025) Vol. 15, Iss. 3, pp. 1698-1712
Open Access
Synthetic product-based approach toward potential antileishmanial drug development
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115927-115927
Closed Access | Times Cited: 14
Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, Molecular insights, and Structure-activity relationship
Nimmagadda Venkata Satya Sai Aishwarya, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139655-139655
Closed Access | Times Cited: 4
T6496 targeting EGFR mediated by T790M or C797S mutant: machine learning, virtual screening and bioactivity evaluation study
Linxiao Wang, Dang Fan, Wei Ruan, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-12
Closed Access | Times Cited: 2
Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR‐Targeted Anticancer Agents
Ketan R Hosamani, K. Hemalatha, Rohit Pal, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access | Times Cited: 1
Advancement of DDR1 and DDR2 Inhibitors: Therapeutic Potential of Bioactive Compounds, Designing Strategies, and Structure‐Activity Relationship (SAR)
Rohit Pal, B. Kumaraswamy, S. K. Md. Ashadul, et al.
ChemistrySelect (2024) Vol. 9, Iss. 30
Closed Access | Times Cited: 1
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
I. Aayishamma, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116831-116831
Closed Access | Times Cited: 1
Exploring Thiazolidine-2,4-dione Derivatives as Privileged Scaffolds for Targeted Anticancer Agents: Biological Activity and Structure-Activity Relationship (SAR) Insights
Mayavan Viji, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024), pp. 140529-140529
Closed Access | Times Cited: 1
Current developments in PI3K-based anticancer agents: Designing strategies, biological activity, selectivity, structure-activity correlation, and docking insight
Md. Ashadul Sk, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108011-108011
Closed Access | Times Cited: 1
Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure–activity relationship
E Haripriya, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Molecular Diversity (2024)
Closed Access
Exploring the Anticancer Potential of Triazine Derivatives: An Outlook of Designing Strategies, Docking Studies, and Structure‐Activity Relationships (SAR)
B V Manjushree, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
ChemistrySelect (2024) Vol. 9, Iss. 41
Open Access
Design, Synthesis, Biological Evaluation and Molecular Docking Study of New 1,3,4‐Thiadiazole‐Based Compounds as EGFR Inhibitors
Marwa I. Serag, Samar S. Tawfik, Hassan M. Eisa, et al.
Drug Development Research (2024) Vol. 86, Iss. 1
Closed Access
Page 1

Scroll to top